BioNTech
Johannes Besser is an experienced professional in the field of pharmacovigilance and R&D digital solutions. Currently serving as Director R&D DD&I Business Partner at BioNTech SE since September 2021, Johannes focuses on providing strategic technology partnerships to the Medical Safety and Pharmacovigilance area, driving growth and innovation by translating business requirements into systems solutions. Prior to this role, Johannes held multiple positions at PharmaLex from April 2016 to August 2021, culminating as Director Pharmacovigilance Safety Systems and leading pharmacovigilance teams. Additional experience includes serving as Medical Advisor Pharmacovigilance at YES Pharma Services GmbH and academic roles, including a postdoctoral position at the Max Planck Institute for Heart and Lung Research. Johannes holds a Diplom in Biology from The Julius Maximilians University of Würzburg.
This person is not in any teams
This person is not in any offices
BioNTech
32 followers
BioNTech was founded in 2008 on the understanding that every cancer patient’s treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide.